Jazz Pharmaceuticals Financial Overview
Jazz Pharmaceuticals's market cap is currently $10.38B. The company's EPS TTM is $8.13; its P/E ratio is -28.14; Jazz Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $6.39. See an overview of income statement, balance sheet, and cash flow financials.
